Guggulsterone: A potent farnesoid X receptor antagonist and its rapidly evolving role as a systemic anticarcinogenic agent

Hepatology

Volumn 48, Issue 6, 2008, Pages 2090-2091

  Kapoor, Shailendra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FARNESOID X RECEPTOR; GUGGULSTERONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT PROTEIN; ANTINEOPLASTIC AGENT; CELL RECEPTOR; DNA BINDING PROTEIN; FARNESOID X-ACTIVATED RECEPTOR; PREGNA 4,17 DIENE 3,16 DIONE; PREGNA-4,17-DIENE-3,16-DIONE; PREGNANE DERIVATIVE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BARRETT ESOPHAGUS; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; DOSE RESPONSE; ESOPHAGUS CARCINOMA; HEART FUNCTION; HUMAN; HYPOLIPEMIA; LETTER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; BREAST TUMOR; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NOTE; PATHOLOGY;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BARRETT ESOPHAGUS; BREAST NEOPLASMS; CELL PROLIFERATION; DNA-BINDING PROTEINS; HUMANS; MELANOMA; PREGNENEDIONES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 58149376551     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22601     Document Type: Letter

References (11)

1. Frankenberg T, Miloh T, Chen FY, Ananthanarayanan M, Sun AQ, Balasubramaniyan N, et al. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor. HEPATOLOGY 2008; doi:10.1002/hep.22431.
2. Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Mukhtar H. Guggulsterone modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in Sencar mice. Carcinogenesis 2008; doi:10.1093/carcin/bgn180.
3. Shishodia S, Sethi G, Ahn KS, Aggarwal BB. Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem Pharmacol 2007;74:118-130.
4. Xiao D, Singh SV. z-Guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, inhibits angiogenesis in vitro and in vivo. Mol Cancer ther 2008;7:171-180.
5. Capello A, Moons LM, Van de Winkel A, Siersema PD, van Dekken H, Kuipers EJ, et al. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus. Am J Gastroenterol 2008;103:1510-1516.
6. De Gottardi A, Dumonceau JM, Bruttin F, Vonlaufen A, Morard I, Spahr L, et al. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer 2006;5: 48.
7. Ahn KS, Sethi G, Sung B, Goel A, Ralhan R, Aggarwal BB. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res 2008;68:4406-4415.
8. Lv N, Song MY, Kim EK, Park JW, Kwon KB, Park BH. Guggulsterone, a plant sterol, inhibits NF-kappaB activation and protects pancreatic beta cells from cytokine toxicity. Molecular and cellular endocrinology 2008; 16;289:49-59.
9. Deng R. Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits. Cardiovasc Drug Rev 2007;25:375-390.
10. Yang JY, Della-Fera MA, Baile CA. Guggulsterone inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 cells. Obesity (Silver Spring) 2008;16:16-22.
11. Lee YR, Lee JH, Noh EM, Kim EK, Song MY, Jung WS, et al. Guggulsterone blocks IL-1beta-mediated inflammatory responses by suppressing NF-kappaB activation in fibroblast-like synoviocytes. Life Sci 2008;82: 1203-1209.